Adherence in allergen immunotherapy: Current situation and future implications

Allergen immunotherapy (AIT) is the only disease-modifying treatment in allergy. However clinical trials as well as real-life studies revealed poor treatment adherence. This article is intended to provide an overview of the current literature of the last 10 years, to outline reasons for poor treatment adherence in AIT and to provide possible solutions for improving adherence.

[1]  M. Wagenmann,et al.  Guideline on allergen immunotherapy in IgE-mediated allergic diseases , 2022, Allergologie select.

[2]  J. Bousquet,et al.  One hundred and ten years of Allergen Immunotherapy: A journey from empiric observation to evidence , 2021, Allergy.

[3]  K. Aksu,et al.  Real-life adherence to subcutaneous immunotherapy: What has changed in the era of the COVID-19 pandemic , 2021, World Allergy Organization Journal.

[4]  D. Wraith,et al.  Peptide allergen‐specific immunotherapy for allergic airway diseases—State of the art , 2021, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[5]  G. Canonica,et al.  Effect of an educational intervention delivered by pharmacists on adherence to treatment, disease control and lung function in patients with asthma. , 2020, Respiratory medicine.

[6]  Wenlong Liu,et al.  Compliance, efficacy, and safety of subcutaneous and sublingual immunotherapy in children with allergic rhinitis , 2020, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[7]  M. Jutel,et al.  Real-World Adherence and Evidence of Subcutaneous and Sublingual Immunotherapy in Grass and Tree Pollen-Induced Allergic Rhinitis and Asthma , 2020, Patient preference and adherence.

[8]  J. Virchow,et al.  Perspectives in allergen immunotherapy: 2019 and beyond , 2019, Allergy.

[9]  P. Demoly,et al.  Immunotherapy with grass pollen tablets reduces medication dispensing for allergic rhinitis and asthma: A retrospective database study in France , 2019, Allergy.

[10]  T. S. Tat.  Adherence to Subcutaneous Allergen Immunotherapy in Southeast Turkey: A Real-Life Study , 2018, Medical science monitor : international medical journal of experimental and clinical research.

[11]  G. Canonica,et al.  Adherence to treatment in allergic respiratory diseases , 2018, Expert review of respiratory medicine.

[12]  A. Sheikh,et al.  EAACI guidelines on allergen immunotherapy: Executive statement , 2018, Allergy.

[13]  A. Sheikh,et al.  EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis , 2018, Allergy.

[14]  P. Demoly,et al.  Perspectives in allergen immunotherapy: 2017 and beyond , 2018, Allergy.

[15]  W. Al-Herz,et al.  Compliance with allergen immunotherapy and factors affecting compliance among patients with respiratory allergies , 2017, Human vaccines & immunotherapeutics.

[16]  M. Turkalj,et al.  A review of clinical efficacy, safety, new developments and adherence to allergen-specific immunotherapy in patients with allergic rhinitis caused by allergy to ragweed pollen (Ambrosia artemisiifolia) , 2017, Patient preference and adherence.

[17]  R. Pawankar,et al.  Rhinitis: adherence to treatment and new technologies , 2017, Current opinion in allergy and clinical immunology.

[18]  R. Mösges,et al.  Sublingual versus subcutaneous immunotherapy: patient adherence at a large German allergy center , 2017, Patient preference and adherence.

[19]  B. Vrijens,et al.  UvA-DARE ( Digital Academic Repository ) What We Mean When We Talk About Adherence in Respiratory Medicine , 2016 .

[20]  M. Bouvy,et al.  Proposal of Standardization to Assess Adherence With Medication Records , 2016, The Annals of pharmacotherapy.

[21]  M. Mauro,et al.  Adherence to Sublingual Immunotherapy , 2016, Current Allergy and Asthma Reports.

[22]  B. Samoliński,et al.  Sublingual immunotherapy (SLIT)--indications, mechanism, and efficacy: Position paper prepared by the Section of Immunotherapy, Polish Society of Allergy. , 2015, Annals of agricultural and environmental medicine : AAEM.

[23]  J. Sánchez,et al.  Adherence to allergen immunotherapy improves when patients choose the route of administration: Subcutaneous or sublingual. , 2015, Allergologia et immunopathologia.

[24]  T. Casale,et al.  The effect of a new communication template on anticipated willingness to initiate or resume allergen immunotherapy: an internet-based patient survey , 2015, Allergy, Asthma & Clinical Immunology.

[25]  L. Klimek,et al.  Prospective adherence to specific immunotherapy in Europe (PASTE) survey protocol , 2015, Clinical and Translational Allergy.

[26]  G. Canonica,et al.  Adherence to asthma treatments: ‘we know, we intend, we advocate’ , 2015, Current opinion in allergy and clinical immunology.

[27]  F. Schellevis,et al.  Innovating care for people with multiple chronic conditions in Europe: An overview , 2015 .

[28]  S. Thum-Oltmer,et al.  Patients’ compliance with different administration routes for allergen immunotherapy in Germany , 2014, Patient preference and adherence.

[29]  P. Demoly,et al.  Characteristics and management of sublingual allergen immunotherapy in children with allergic rhinitis and asthma induced by house dust mite allergens , 2014, Clinical and Translational Allergy.

[30]  J. Bousquet,et al.  Sublingual immunotherapy: World Allergy Organization position paper 2013 update , 2014, The World Allergy Organization journal.

[31]  B. Bender,et al.  The special challenge of nonadherence with sublingual immunotherapy. , 2014, The journal of allergy and clinical immunology. In practice.

[32]  N. Santos,et al.  Costs of treatment affect compliance to specific subcutaneous immunotherapy. , 2014, European annals of allergy and clinical immunology.

[33]  R. Lockey,et al.  Allergy immunotherapy adherence and delivery route: location does not matter. , 2014, The journal of allergy and clinical immunology. In practice.

[34]  J. Yusin,et al.  A retrospective review of veterans' adherence to allergen immunotherapy over 10 years. , 2014, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[35]  W. Reisacher,et al.  Patient adherence to allergy immunotherapy , 2013, Current opinion in otolaryngology & head and neck surgery.

[36]  T. Casale,et al.  Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report. , 2013, The Journal of allergy and clinical immunology.

[37]  G. Canonica,et al.  Patient knowledge, perceptions, expectations and satisfaction on allergen-specific immunotherapy: a survey. , 2013, Respiratory medicine.

[38]  G. Passalacqua,et al.  Adherence to pharmacological treatment and specific immunotherapy in allergic rhinitis , 2013, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[39]  W. Hop,et al.  Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy. , 2012, The Journal of allergy and clinical immunology.

[40]  J. Dai,et al.  [Causes of stopping subcutaneous specific immunotherapy in asthmatic children]. , 2012, Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics.

[41]  W. Reisacher,et al.  A comparison of attrition rates in patients undergoing sublingual immunotherapy vs subcutaneous immunotherapy , 2012, International forum of allergy & rhinology.

[42]  S. Durham,et al.  Rhinitis , sinusitis , and upper airway disease SQ-standardized sublingual grass immunotherapy : Confirmation of disease modification 2 years after 3 years of treatment in a randomized trial , 2012 .

[43]  G. Passalacqua,et al.  Adherence to sublingual immunotherapy in preschool children , 2011, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[44]  P. Kuna,et al.  Subcutaneous immunotherapy and pharmacotherapy in seasonal allergic rhinitis: a comparison based on meta-analyses. , 2011, The Journal of allergy and clinical immunology.

[45]  C. Rhee,et al.  Sublingual immunotherapy in allergic rhinitis , 2011, Asia Pacific allergy.

[46]  E. Weinberg,et al.  The WAO White Book on Allergy 2011 - 2012 : review article , 2011 .

[47]  R. Mösges,et al.  Medication persistence with long-term, specific grass pollen immunotherapy measured by prescription renewal rates , 2011, Current medical research and opinion.

[48]  F. Frati,et al.  Importance of patient’s education in favouring compliance with sublingual immunotherapy , 2010, Allergy.

[49]  G. Canonica,et al.  How adherent to sublingual immunotherapy prescriptions are patients? The manufacturers' viewpoint. , 2010, The Journal of allergy and clinical immunology.

[50]  G. Pajno,et al.  Sublingual immunotherapy: adherence based on timing and monitoring control visits , 2010, Allergy.

[51]  P. Mahesh,et al.  Factors associated with non-adherence to specific allergen immunotherapy in management of respiratory allergy. , 2010, The Indian journal of chest diseases & allied sciences.

[52]  G. Canonica,et al.  Evidence of adherence to allergen-specific immunotherapy , 2009, Current opinion in allergy and clinical immunology.

[53]  S. Vieths,et al.  Sub‐lingual Immunotherapy: World Allergy Organization Position Paper 2009 , 2009, Allergy.

[54]  G. Marseglia,et al.  Sublingual immunotherapy in children: facts and needs , 2009, Italian journal of pediatrics.

[55]  L. Klimek,et al.  Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study , 2009, Allergy.

[56]  Jeong-Whun Kim,et al.  Early Compliance and Efficacy of Sublingual Immunotherapy in Patients with Allergic Rhinitis for House Dust Mites , 2009, Clinical and experimental otorhinolaryngology.

[57]  D. Campbell.  Sublingual immunotherapy for children: Are we there yet? Defining its role in clinical practice. , 2009, Paediatric respiratory reviews.

[58]  A. Jansen,et al.  Evaluation of a compliance device in a subgroup of adult patients receiving specific immunotherapy with grass allergen tablets (GRAZAX) in a randomized, open-label, controlled study: an a priori subgroup analysis. , 2009, Clinical therapeutics.

[59]  A. Sheikh,et al.  Allergen injection immunotherapy for seasonal allergic rhinitis. , 2007, The Cochrane database of systematic reviews.

[60]  G. Pajno,et al.  Children's compliance with allergen immunotherapy according to administration routes. , 2005, The Journal of allergy and clinical immunology.

[61]  A. Lippman.  Adherence to medication. , 2005, The New England journal of medicine.

[62]  A. L. Dal-Fabbro,et al.  Adherence to long term therapies: evidence for action , 2005 .

[63]  G. Passalacqua,et al.  Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real‐life: clinical efficacy and more , 2004, Allergy.

[64]  S. Burastero,et al.  Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. , 2004, The Journal of allergy and clinical immunology.

[65]  G. Canonica,et al.  Quantitative assessment of the adherence to sublingual immunotherapy. , 2004, The Journal of allergy and clinical immunology.

[66]  S. De Geest,et al.  Adherence to Long-Term Therapies: Evidence for Action , 2003, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

[67]  S. Kivity,et al.  Knowledge and expectations of patients receiving aeroallergen immunotherapy. , 2002, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[68]  A. Stewart,et al.  Chronic Disease Self-Management Program: 2-Year Health Status and Health Care Utilization Outcomes , 2001, Medical care.

[69]  N. York,et al.  Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six‐year follow‐up study. , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[70]  S. Durham,et al.  Allergen immunotherapy: does it work and, if so, how and for how long? , 2000, Thorax.